Harshal Deshmukh

ORCID: 0000-0002-3859-3118
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Management and Research
  • Ovarian function and disorders
  • Diabetes Treatment and Management
  • Genetic Associations and Epidemiology
  • Diabetes and associated disorders
  • Diabetes Management and Education
  • Reproductive Biology and Fertility
  • Pancreatic function and diabetes
  • Liver Disease Diagnosis and Treatment
  • Growth Hormone and Insulin-like Growth Factors
  • Adrenal and Paraganglionic Tumors
  • Chronic Kidney Disease and Diabetes
  • Renal Diseases and Glomerulopathies
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Lipoproteins and Cardiovascular Health
  • Chronic Disease Management Strategies
  • Ovarian cancer diagnosis and treatment
  • Metabolism, Diabetes, and Cancer
  • Cardiovascular Function and Risk Factors
  • Bioinformatics and Genomic Networks
  • Pituitary Gland Disorders and Treatments
  • Systemic Lupus Erythematosus Research
  • Hormonal and reproductive studies
  • Hormonal Regulation and Hypertension
  • Cancer, Lipids, and Metabolism

University of Hull
2018-2025

Mackay Base Hospital
2024-2025

James Cook University
2024-2025

Queensland Health
2025

National Health Service
2025

Hull York Medical School
2018-2024

University Teaching Hospital
2021-2023

Newcastle University
2016-2023

University Hospitals of Derby and Burton NHS Foundation Trust
2022

Hull Royal Infirmary
2022

Natalie R. van Zuydam Emma Ahlqvist Niina Sandholm Harshal Deshmukh Nigel W. Rayner and 95 more Moustafa Abdalla Claes Ladenvall Daniel Ziemek Eric B. Fauman Neil R. Robertson Paul McKeigue Erkka Valo Carol Forsblom Valma Harjutsalo Annalisa Perna Erica Rurali M. Loredana Marcovecchio Robert P. Igo Rany M. Salem Norberto Perico Maria Lajer Annemari Käräjämäki Minako Imamura Michiaki Kubo Atsushi Takahashi Xueling Sim Jianjun Liu Rob M. van Dam Guozhi Jiang Claudia H.T. Tam Andrea O. Y. Luk Heung Man Lee Cadmon K.P. Lim Cheuk‐Chun Szeto Wing Yee So Juliana C.N. Chan Su Fen Ang Rajkumar Dorajoo Ling Wang Tan Si Hua Clara Amy Jayne McKnight Seamus Duffy Marcus G. Pezzolesi Michel Marre Beata Gyorgy Samy Hadjadj Linda T. Hiraki Tarunveer S. Ahluwalia Peter Almgren Christina‐Alexandra Schulz Marju Orho‐Melander Allan Linneberg Cramer Christensen Daniel R. Witte Niels Grarup Ivan Brandslund Olle Melander Andrew D. Paterson David‐Alexandre Trégouët Alexander P. Maxwell Su Chi Lim Ronald C.W. E Shyong Tai Shiro Maeda Valeriya Lyssenko Jaakko Tuomilehto Andrzej S. Królewski Stephen S. Rich Joel N. Hirschhorn José C. Florez David B. Dunger Oluf Pedersen Torben Hansen Peter Rossing Giuseppe Remuzzi M. Julia Brosnan Nicholette D. Palmer Per‐Henrik Groop Helen M. Colhoun Leif Groop Mark I. McCarthy Satu Koivula T. Uggeldahl Terje Forslund A. Halonen A. Koistinen P. Koskiaho M. Laukkanen Juha Saltevo Miia Tiihonen M. Forsen Helena Granlund A.-C. Jönsson B. Nyroos Pentti Kinnunen A. Orvola Tapani Salonen A. Vähänen Kotka R. Paldanius M Riihelä

Identification of sequence variants robustly associated with predisposition to diabetic kidney disease (DKD) has the potential provide insights into pathophysiological mechanisms responsible. We conducted a genome-wide association study (GWAS) DKD in type 2 diabetes (T2D) using eight complementary dichotomous and quantitative phenotypes: principal analysis involved 5,717 T2D subjects, 3,345 DKD. Promising signals were evaluated up 26,827 subjects (12,710 DKD). A combined T1D+T2D GWAS was...

10.2337/db17-0914 article EN Diabetes 2018-04-27

OBJECTIVE The FreeStyle Libre (FSL) flash glucose-monitoring device was made available on the U.K. National Health Service (NHS) drug tariff in 2017. This study aims to explore real-world experience of FSL and impact glycemic control, hypoglycemia, diabetes-related distress, hospital admissions. RESEARCH DESIGN AND METHODS Clinicians from 102 NHS hospitals submitted user data, collected during routine clinical care, a secure web-based tool held within N3 network. t Mann-Whitney U tests were...

10.2337/dc20-0738 article EN Diabetes Care 2020-07-15

Circulating levels of soluble receptor for advanced glycation end products (sRAGE) likely comprise both a secreted isoform (esRAGE) and wild-type RAGE cleaved from the cell membrane. Both sRAGE esRAGE have been proposed as biomarkers cardiovascular disease (CVD), but prospective data are limited. We examined relationship to incident coronary heart (CHD) stroke in type 2 diabetic patients followed 3.9 years trial atorvastatin: Collaborative Atorvastatin Diabetes Study (CARDS).We used nested...

10.2337/db11-0291 article EN cc-by-nc-nd Diabetes 2011-07-20

What is the predicted risk of acute kidney injury after orthopaedic surgery and does it affect short term long survival?The cohort comprised adults resident in National Health Service Tayside region Scotland who underwent from 1 January 2005 to 31 December 2011. The model was developed 6220 patients (two hospitals) externally validated 4395 a third hospital. Several preoperative variables were selected for candidate predictors, based on literature, clinical expertise, availability setting....

10.1136/bmj.h5639 article EN cc-by-nc BMJ 2015-11-11

We carried out a genome-wide association study (GWAS) of LDL-c response to statin using data from participants in the Collaborative Atorvastatin Diabetes Study (CARDS; n = 1,156), Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT; 895), and observational phase ASCOT (n 651), all whom were prescribed atorvastatin 10 mg. Following imputation, we combined three studies meta-analysis. found associations that reached significance at rs10455872 (P= 6.13 × 10−9) within LPA gene two single nucleotide...

10.1194/jlr.p021113 article EN cc-by Journal of Lipid Research 2012-02-26

Metformin is a first-line oral agent used in the treatment of type 2 diabetes, but glycaemic response to this drug highly variable. Understanding genetic contribution metformin might increase possibility personalising treatment. We aimed establish heritability using genome-wide complex trait analysis (GCTA) method.

10.1016/s2213-8587(14)70050-6 article EN cc-by The Lancet Diabetes & Endocrinology 2014-03-21

Diabetes is the leading cause of ESRD. Despite evidence for a substantial heritability diabetic kidney disease, efforts to identify genetic susceptibility variants have had limited success. We extended previous in three dimensions, examining more comprehensive set larger numbers subjects with type 1 diabetes characterized wider range cross-sectional disease phenotypes. In 2843 subjects, we estimated that was 35% (P=6.4×10-3). Genome-wide association analysis and replication 12,540...

10.1681/asn.2016020231 article EN Journal of the American Society of Nephrology 2016-09-19

Summary Background Empagliflozin is a sodium‐glucose‐cotransporter‐2 inhibitor that improves cardiovascular risk and promotes weight loss in patients with type‐2 diabetes. Polycystic ovary syndrome (PCOS) associated obesity increased risk; therefore, empagliflozin may be of benefit for these women. The aim this study was to compare the effects vs metformin on anthropometric body composition, hormonal metabolic parameters women PCOS. Materials methods A randomized open‐label conducted PCOS...

10.1111/cen.13968 article EN Clinical Endocrinology 2019-03-13

Polycystic ovary syndrome (PCOS) increases the risk of metabolic and non-alcoholic-fatty-liver disease (NAFLD). Vitamin D supplementation may exert positive effects on liver biochemistry in patients with NAFLD; however, its PCOS are unknown. This randomized, double-blind, placebo-controlled study explored effect vitamin cardiovascular factors (high-sensitivity C-reactive protein (hs-CRP), weight, body mass index (BMI), lipid profile, glucose levels, insulin homeostatic model...

10.3390/nu11010188 article EN Nutrients 2019-01-17
Adem Y. Dawed Andrea Mari Andrew Brown Timothy J. McDonald Lin Li and 95 more Shuaicheng Wang Mun‐Gwan Hong Sapna Sharma Neil R. Robertson Anubha Mahajan Xuan Wang Mark Walker Stephen Gough Leen M. ‘t Hart Kaixin Zhou Ian Forgie Hartmut Ruetten Imre Pávó Pallav Bhatnagar Angus G. Jones Ewan R. Pearson Leen M. ‘t Hart Mohamed Elhassan Abdalla Jean‐Michel Adam J. Adamski Kofi P. Adragni Kristine H. Allin Manimozhiyan Arumugam Naeimeh Atabaki Pasdar Tania Baltauss Kamil Banasik Patrick Baum Jimmy D. Bell Mats Bergström Joline W. J. Beulens Susaana Bianzano Roberto Bizzotto Amelie Bonneford Caroline Brorsson A.A. Brown S.B. Brunak Louise Cabrelli Robert Caïazzo Mickaël Canouil M.M. Dale David Davtian Adem Y. Dawed F.M. De Masi Nathalie de Préville Koen F. Dekkers E. T. Dermitzakis Harshal Deshmukh Christiane Dings Louise Donnelly Avirup Dutta Beate Ehrhardt Petra J. M. Elders Cecilia Engel Thomas Line Engelbrechtsen R.G. Eriksen R.E. Eriksen Yong Fan J. Fernandez José Illnait Ferrer Hugo Fitipaldi Ian Forgie Axel Forman Paul W. Franks Franco Frau A. Fritsche P. Froguel Gary Frost Johann Gassenhuber Guillermo Giordano Toni Giorgino Stephen Gough Ulrike Graefe‐Mody H. Grallert Rolf Grempler Lenka Groeneveld Leif Groop V Gudmundsdottir R.G. Gupta Mark Haid T. Hansen Tue H. Hansen Andrew T. Hattersley Ragna S. Häussler A.J. Heggie Anita M. Hennige Adrian V. S. Hill Reinhard W. Holl Mun‐Gwan Hong Michelle Hudson Bernd Jablonka Christopher Jennison Jian Jiao Jon Johansen Adam G. Jones A. Jonsson

10.1016/s2213-8587(22)00340-0 article EN The Lancet Diabetes & Endocrinology 2022-12-15

OBJECTIVE This study aimed to explore the relationship between time below range (TBR), impaired awareness of hypoglycemia (IAH), and severe (SH). RESEARCH DESIGN AND METHODS cross-sectional analyzed data from individuals with diabetes using continuous glucose monitors (CGMs) in Association British Clinical Diabetologists audit. Hypoglycemia was assessed via Gold score (≥4 denoting IAH), SH defined as requiring third-party assistance. Logistic regression used determine association TBR...

10.2337/dc24-1833 article EN Diabetes Care 2025-01-02

Purpose Despite a lack of evidence for survival benefit, the American College Obstetrics and Gynecology has recommendations referral to gynecologic oncologists treatment endometrial cancer. Therefore, we propose determine influence on patients with Patients Methods Data were obtained from Medicare Surveillance, Epidemiology, End Results (SEER) databases 1988 2005. Kaplan-Meier Cox proportional hazard methods used analyses. Of 18,338 women, 21.4% received care (group A) while 78.6% treated by...

10.1200/jco.2010.31.2124 article EN Journal of Clinical Oncology 2011-01-25

Neuropathic pain, caused by a lesion or disease affecting the somatosensory system, is one of most common complications in diabetic patients. The purpose this study to identify genetic factors contributing type pain general population.We accessed Genetics Diabetes Audit and Research Tayside (GoDARTS) datasets that contain prescription information monofilament test results for 9439 patients, among which 6927 individuals were genotyped Affymetrix SNP6.0 Illumina OmniExpress chips. Cases...

10.1002/ejp.560 article EN cc-by European Journal of Pain 2014-06-27

Osteopontin (SPP1) is an important bone matrix mediator found to have key roles in inflammation and immunity. SPP1 genetic polymorphisms increased osteopontin protein levels been reported be associated with SLE small patient collections. The present study evaluates association between a large cohort of 1141 unrelated patients [707 European-American (EA) 434 African-American (AA)], 2009 controls (1309 EA 700 AA). Population-based case-control analyses were performed. To control for potential...

10.1371/journal.pone.0001757 article EN cc-by PLoS ONE 2008-03-12
Daniel I. Chasman Christian Fuchsberger Cristian Pattaro Alexander Teumer Carsten A. Böger and 95 more Karlhans Endlich Matthias Olden Ming‐Huei Chen Adrienne Tin Daniel Taliun Man Li Xiaoyi Gao Mathias Gorski Qiong Yang Claudia Hundertmark Meredith C. Foster Conall M. O’Seaghdha Nicole L. Glazer Aaron Isaacs Yongmei Liu Albert V. Smith Jeffrey R. O’Connell Maksim Struchalin Toshiko Tanaka Li Guo Andrew D. Johnson Hinco J. Gierman Mary F. Feitosa Shih-Jen Hwang Elizabeth J. Atkinson Kurt Lohman Marilyn C. Cornelis Åsa Johansson Anke Tönjes Abbas Dehghan Jean‐Charles Lambert Elizabeth G. Holliday Rossella Sorice Zoltán Kutalik Terho Lehtimäki Tõnu Esko Harshal Deshmukh Sheila Ulivi Audrey Y. Chu Federico Murgia Stella Trompet Medea Imboden Stefan Coassin Giorgio Pistis Tamara B. Harris Lenore J. Launer Thor Aspelund Guðný Eiríksdóttir Braxton D. Mitchell Eric Boerwinkle Helena Schmidt Margherita Cavalieri Madhumathi Rao Frank B. Hu Ayşe Demirkan Ben A. Oostra Mariza de Andrade Stephen T. Turner Jingzhong Ding Jeanette S. Andrews Barry I. Freedman Franco Giulianini Wolfgang Köenig Thomas Illig Christa Meisinger Christian Gieger Lina Zgaga Tatijana Zemunik Mladen Boban Cosetta Minelli Heather E. Wheeler Wilmar Igl Ghazal Zaboli Sarah H. Wild Alan F. Wright Harry Campbell David Ellinghaus Ute Nöthlings Gunnar Jacobs Reiner Biffar Florian Ernst Georg Homuth Heyo K. Kroemer Matthias Nauck Sylvia Stracke Uwe Völker Henry Völzke Péter Kovács Michael Stümvoll Reedik Mägi Albert Hofman André G. Uitterlinden Fernando Rivadeneira Yurii S. Aulchenko Ozren Polašek

In conducting genome-wide association studies (GWAS), analytical approaches leveraging biological information may further understanding of the pathophysiology clinical traits. To discover novel associations with estimated glomerular filtration rate (eGFR), a measure kidney function, we developed strategy for integrating prior knowledge into existing GWAS data eGFR from CKDGen Consortium. Our focuses on single nucleotide polymorphism (SNPs) in genes that are connected by functional evidence,...

10.1093/hmg/dds369 article EN Human Molecular Genetics 2012-09-08
Coming Soon ...